Robin A Weiss

Q: What Schools Are Affiliated With Robin A Weiss

Robin A Weiss is affiliated with the following schools: Institute of Cancer Research, University College London, University of Washington, Duke University, University of Pennsylvania

Robin A Weiss's AcademicInfluence.com Rankings

Robin A Weiss

Biology

#3971

World Rank

#5994

Historical Rank

Virology

#62

World Rank

#65

Historical Rank

Microbiology

#123

World Rank

#147

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Robin A Weiss Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robin A Weiss's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus (1984) (3590)
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain (1986) (2039)
Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV (1996) (956)
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma (1995) (894)
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. (1999) (717)
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells (1995) (717)
High-titer packaging cells producing recombinant retroviruses resistant to human serum (1995) (706)
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen (1996) (653)
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. (2000) (632)
Dissociation of gp120 from HIV-1 virions induced by soluble CD4. (1990) (612)
Social and environmental risk factors in the emergence of infectious diseases (2004) (569)
Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes (1984) (537)
How does HIV cause AIDS (1993) (534)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals (2010) (458)
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. (2010) (453)
Keratin classes: molecular markers for different types of epithelial differentiation. (1983) (434)
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients (1985) (426)
Two sets of human-tropic pig retrovirus (1997) (408)
Clonal Origin and Evolution of a Transmissible Cancer (2006) (402)
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry (1996) (401)
The CD4 antigen: Physiological ligand and HIV receptor (1988) (391)
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway (1997) (373)
Epitopes of the CD4 antigen and HIV infection. (1986) (359)
The discovery of endogenous retroviruses (2006) (352)
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells (1989) (347)
Identification of the residues in human CD4 critical for the binding of HIV (1989) (341)
Kaposi's sarcoma-associated herpesvirus. (1997) (310)
T Cell Responses to Whole SARS Coronavirus in Humans1 (2008) (310)
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 (1997) (307)
No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys (1998) (301)
Variable and conserved neutralization antigens of human immunodeficiency virus (1986) (292)
Host range and interference studies of three classes of pig endogenous retrovirus. (1999) (284)
Aids-related malignancies (2002) (283)
Antibodies against human herpesvirus 8 in black South African patients with cancer. (1999) (272)
Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus (1991) (270)
Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. (1998) (265)
Receptor interference groups of 20 retroviruses plating on human cells. (1990) (264)
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors (2015) (260)
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell (1994) (250)
Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase (1996) (248)
Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. (1971) (244)
Retroviral retargeting by envelopes expressing an N-terminal binding domain (1995) (241)
Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses. (1973) (235)
A Quantitative Meta-Analysis of Functional Imaging Studies of Social Rejection (2013) (232)
HIV infection does not require endocytosis of its receptor, CD4 (1988) (228)
Cellular Receptors and Viral Glycoproteins Involved in Retrovirus Entry (1993) (227)
Origins of HIV and the Evolution of Resistance to AIDS (2006) (226)
PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN (1984) (226)
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. (1998) (224)
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies (1989) (223)
The pH independence of mammalian retrovirus infection. (1990) (222)
Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. (1983) (222)
Characterization of HIV‐1 neutralization escape mutants (1989) (218)
Multiple Groups of Novel Retroviral Genomes in Pigs and Related Species (2001) (208)
Human T‐cell leukemia virus type I: Induction of syncytia and inhibition by patients' sera (1983) (207)
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile (2003) (203)
Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex (1999) (189)
Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. (1987) (187)
Virus infection of murine teratocarcinoma stem cell lines (1977) (187)
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. (2008) (186)
Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4 (1992) (181)
A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism (1993) (179)
Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. (1999) (177)
Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. (1992) (173)
Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. (1995) (171)
Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. (2001) (170)
Human RNA “Rumor” Viruses: the Search for Novel Human Retroviruses in Chronic Disease (2008) (168)
Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes (2005) (162)
CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. (1997) (162)
Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. (1997) (162)
Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules (2011) (157)
Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus (1992) (157)
Human T cell leukemia viruses use a receptor determined by human chromosome 17. (1988) (156)
The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. (1988) (152)
Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera. (1984) (147)
Identification of receptors for pig endogenous retrovirus (2003) (145)
Neutralizing antibodies to HIV-1 induced by immunization (2013) (143)
Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. (1999) (143)
Transmissible Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage (2014) (142)
HIV-1 tropism and co-receptor use (1997) (141)
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies (2007) (140)
Host Range and Interference Studies of Three Classes of Pig Endogenous Retrovirus (1998) (138)
The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. (1983) (138)
Detection of human herpesvirus 8 DNA in semen from HIV‐infected individuals but not healthy semen donors (1997) (138)
HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIII (1985) (138)
Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion (1997) (135)
The Host Range of bryan Strain Rous Sarcoma Virus Synthesized in the Absence of Helper Virus (1969) (135)
HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor (1990) (134)
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120 (2008) (130)
Neutralizing monoclonal antibodies to the AIDS virus. (1988) (129)
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. (1998) (128)
Our retroviral heritage. (1997) (126)
Detection of avian tumor virus-specific nucleotide sequences in avian cell DNAs (reassociation kinetics-RNA tumor viruses-gas antigen-Rous sarcoma virus, chick cells). (1972) (124)
LOW PREVALENCE IN THE UK OF HTLV-I AND HTLV-II INFECTION IN SUBJECTS WITH AIDS, WITH EXTENDED LYMPHADENOPATHY, AND AT RISK OF AIDS (1984) (123)
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. (1988) (120)
The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. (1993) (119)
Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. (1988) (118)
Scanning electron microscopy of cells in culture. (1972) (116)
The Leeuwenhoek Lecture 2001. Animal origins of human infectious disease. (2001) (116)
Immunodeficiency viruses: Spoilt for choice of co-receptors (1997) (114)
Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. (1996) (113)
The distribution of endogenous chicken retrovirus sequences in the DNA of galliform birds does not coincide with avian phylogenetic relationships (1979) (113)
HIV infection of primate lymphocytes and conservation of the CD4 receptor (1987) (112)
HTLV-III SEROLOGY DISTINGUISHES ATYPICAL AND ENDEMIC KAPOSI'S SARCOMA IN AFRICA (1985) (112)
Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. (2001) (112)
Evidence and Consequence of Porcine Endogenous Retrovirus Recombination (2004) (111)
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization (2012) (110)
Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy (2002) (107)
Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century (2009) (106)
Identification of Human Herpesvirus 8-Specific Cytotoxic T-Cell Responses (1999) (106)
Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups (1997) (106)
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison (2008) (103)
Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. (1983) (101)
Retrovirus receptors (1995) (100)
Xenografts and Retroviruses (1999) (99)
Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? (1992) (97)
Cell cycle dependence of foamy retrovirus infection (1995) (96)
Change in tropism upon immune escape by human immunodeficiency virus (1995) (95)
A dominant epistatic gene which inhibits cellular susceptibility to RSV(RAV-O). (1971) (95)
Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. (1990) (94)
HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. (1991) (94)
Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins (1992) (94)
100 years of Rous sarcoma virus (2011) (93)
The Promiscuous CC Chemokine Receptor D6 Is a Functional Coreceptor for Primary Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 on Astrocytes (2005) (92)
A novel exogenous retrovirus sequence identified in humans (1997) (92)
Host gene control of endogenous avian leukosis virus production. (1974) (91)
From Pan to pandemic (1999) (90)
Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. (2011) (89)
Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. (1999) (86)
Characterization of Monoclonal Antibodies Raised against the Latent Nuclear Antigen of Human Herpesvirus 8 (1999) (85)
Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. (1996) (85)
Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia (1990) (85)
Virulence and pathogenesis. (2002) (84)
The heritable nature of the factor in chicken cells which acts as a helper virus for Rous sarcoma virus. (1971) (81)
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection (2011) (81)
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission (2000) (79)
Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. (1996) (79)
Cell locomotion and contact inhibition of normal and neoplastic rat cells (1973) (78)
Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41 (2010) (78)
A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition (2013) (77)
A Boost for HIV Vaccine Design (2010) (77)
Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections (1993) (74)
Gulliver's travels in HIVland (2001) (74)
Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. (1993) (74)
Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation (1997) (74)
HIV-2 antisera cross-neutralize HIV-1. (1988) (73)
Packaging of Endogenous Retroviral Sequences in Retroviral Vectors Produced by Murine and Human Packaging Cells (1998) (73)
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. (2011) (73)
The sero‐epidemiology of Kaposi's sarcoma‐associated herpesvirus (KSHV/HHV‐8) in adults with cancer in Uganda (2003) (73)
Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry. (1997) (72)
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-1 (1990) (72)
HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. (1994) (71)
Risk factors for Kaposi's sarcoma: A case‐control study of HIV‐seronegative people in Uganda (2003) (71)
Susceptibility of the Porcine Endogenous Retrovirus to Reverse Transcriptase and Protease Inhibitors (2001) (69)
HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. (2005) (69)
Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line (1996) (68)
Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature (1979) (68)
Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus. (1977) (65)
A cautionary tale of virus and disease (2010) (65)
Special Anniversary Review: Twenty-five years of human immunodeficiency virus research: successes and challenges (2008) (64)
Pseudotypes of vesicular stomatitis virus determined by exogenous and endogenous avian RNA tumor viruses. (1974) (63)
Spontaneous virus production from "non-virus producing" Rous sarcoma cells. (1967) (62)
Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. (1987) (61)
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis (2016) (61)
Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C (2012) (61)
Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses (2010) (61)
Viral DNA in bursal lymphomas induced by avian leukosis viruses (1980) (60)
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge. (2015) (60)
Envelope properties of human T-cell leukemia viruses. (1985) (59)
Human oncogenic viruses: nature and discovery (2017) (59)
Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. (1999) (59)
Interference and Neutralization Studies with Bryan Strain Rous Sarcoma Virus Synthesized in the Absence of Helper Virus (1969) (59)
Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro. (1991) (56)
On HIV diversity. (2012) (56)
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. (2009) (55)
Infectogenomics: Insights from the Host Genome into Infectious Diseases (2006) (55)
Phenotypic mixing between avian and mammalian RNA tumor viruses: I. Envelope pseudotypes of Rous sarcoma virus. (1977) (54)
Potent Autologous and Heterologous Neutralizing Antibody Responses Occur in HIV-2 Infection across a Broad Range of Infection Outcomes (2011) (53)
CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry (1997) (53)
Isolation of a new foamy retrovirus from orangutans (1994) (53)
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. (1989) (53)
Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses. (1980) (53)
A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa (2009) (53)
Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR (1997) (52)
Virus envelope markers in mammalian tropism of avian RNA tumor viruses (1975) (52)
ISOLATION OF RETROVIRUSES FROM TWO PATIENTS WITH "COMMON VARIABLE" HYPOGAMMAGLOBULINAEMIA (1986) (52)
Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. (1992) (52)
CD4-dependent and CD4-independent HIV-2: consequences for neutralization (2003) (49)
T cells reactive to an inducible heat shock protein induce disease in toxin-induced interstitial nephritis (1994) (49)
Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. (1989) (49)
Selective isolation of mutants of vesicular stomatitis virus defective in production of the viral glycoprotein (1979) (48)
Why is HIV a pathogen? (2008) (47)
Multistage carcinogenesis (2004) (47)
Leukosis and Marek's disease viruses of feral red jungle flow and domestic fowl in Malaya. (1972) (47)
Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. (1992) (46)
A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein–Barr virus in adults with human immunodeficiency virus-1 (2006) (44)
Malignant smooth muscle tumors of the gastrointestinal tract: an ultrastructural study of 20 cases. (1981) (44)
PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. (2002) (44)
Zoonosis in xenotransplantation. (1998) (44)
Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site. (1992) (44)
Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1* (2010) (44)
Proposal for Numbering Mutants of Avian Leukosis and Sarcoma Viruses (1974) (44)
HIV Receptors and Cellular Tropism (2002) (43)
Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage. (1993) (42)
Polio vaccines exonerated (2001) (42)
The T4 glycoprotein is a cell-surface receptor for the AIDS virus. (1986) (42)
The prevention and eradication of smallpox: a commentary on Sloane (1755) ‘An account of inoculation’ (2015) (41)
Detection of SV40 sequences in human mesothelioma. (1998) (41)
Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors. (1993) (41)
Human T‐cell leukemia virus type I: Pseudotype neutralization of Japanese And American isolates with human and rabbit sera (1985) (41)
Immunohistochemistry of Warthin's tumor. (1980) (41)
Neutralisation of HIV-1 cell-cell spread by human and llama antibodies (2014) (41)
Localization of the receptor gene for type D simian retroviruses on human chromosome 19 (1990) (40)
Cross-species infections. (2003) (40)
Pseudotypes of vesicular stomatitis virus with the envelope properties of mammalian and primate retroviruses (1977) (40)
Hot fusion of HIV (1996) (40)
Viruses and Langerhans cell histiocytosis: is there a link? (1994) (40)
Human herpesvirus 8 in lymphoma and Kaposi's sarcoma: Now the virus can be propagated (1996) (39)
Phenotypic mixing between vesicular stomatitis virus and avian RNA tumor viruses. (1975) (39)
Studies in healthy human T‐cell‐leukemia lymphoma virus (HTLV‐I) carriers from the Caribbean (1986) (38)
Towards an ultra-rapid smartphone- connected test for infectious diseases (2017) (38)
Endogenous Retroviruses: A Potential Problem for Xenotransplantation? a (1998) (37)
The influence of normal cells on the proliferation of tumour cells in culture. (1970) (37)
Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor (2018) (37)
Llama antibody fragments have good potential for application as HIV type 1 topical microbicides. (2012) (37)
Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction (2010) (37)
Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity (1991) (36)
Apes, lice and prehistory (2009) (36)
Our Viral Inheritance (2013) (36)
On the concept and elucidation of endogenous retroviruses (2013) (36)
Monoclonal antikeratin antibody: production, characterization, and immunohistochemical application. (1985) (35)
Tissue immunomicroscopic evaluation of monoclonality of B-cell lymphomas: comparison with cell suspension studies. (1981) (35)
Development of HIV‐1 group‐specific neutralizing antibodies after seroconversion (1992) (35)
Novel Endogenous Retrovirus in Rabbits Previously Reported as Human Retrovirus 5 (2002) (34)
What have we learnt from SARS? (2004) (34)
Human retrovirus-5 proviral DNA is rarely detected in salivary gland biopsy tissues from patients with Sjögren's syndrome. (1997) (33)
Immunohistochemistry of fresh-frozen lymphoid tissue with the direct immunoperoxidase technic. (1981) (33)
CLINICAL FINDINGS AND SEROLOGICAL EVIDENCE OF HTLV-III INFECTION IN HOMOSEXUAL CONTACTS OF PATIENTS WITH AIDS AND PERSISTENT GENERALISED LYMPHADENOPATHY IN LONDON (1984) (33)
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1 (2014) (33)
Human immunodeficiency viruses: neutralization and receptors. (1988) (32)
Dextrin Sulphate and Fucoidan are Potent Inhibitors of HIV Infection in vitro (1991) (32)
Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda (2003) (31)
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. (1990) (31)
Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights. (2017) (31)
RNA tumour viruses (1977) (31)
HIV and AIDS: looking ahead (2003) (31)
Viral RNA‐dependent DNA polymerase RNA‐dependent DNA polymerase in virions of Rous sarcoma virus (1998) (30)
Aetiology of Kaposi's sarcoma: current understanding and implications for therapy. (1997) (30)
An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group. (1999) (30)
Infection hazards of xenotransplantation. (2000) (30)
A measles virus isolate from a child with Kawasaki disease: sequence comparison with contemporaneous isolates from 'classical' cases. (1992) (30)
Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-α(1-3) Galactosyl Epitope (2004) (29)
Xenotransplantation: reappraising the risk of retroviral zoonosis. (2000) (29)
Science, medicine, and the future: Xenotransplantation (1998) (29)
T cell lymphoma occurring in Sjögren's syndrome. (1984) (29)
A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene. (1991) (29)
Postnatal Maturation of Pulmonary Antimicrobial Defense Mechanisms in Conventional and Germ- Free Lambs (1986) (28)
Differences between the endogenous and exogenous dna sequences of rous-associated virus-O (1979) (28)
Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B) (1995) (27)
Thirty years on: HIV receptor gymnastics and the prevention of infection (2013) (26)
Nanobodies that Neutralize HIV (2019) (26)
A search for genetic effects of high natural radioactivity in South India. (1966) (26)
The receptor for HIV: dissection of CD4 and studies on putative accessory factors. (1996) (25)
HIV and the new viruses (1999) (25)
HIV and AIDS in relation to other pandemics (2003) (24)
Human endogenous retroviruses: friend or foe? (2016) (24)
Use of vesicular stomatitis virus pseudotypes to map viral receptor genes: Assignment of RD114 virus receptor gene to human chromosome 19 (1980) (24)
Dynamic spatiotemporal brain analyses using high performance electrical neuroimaging: Theoretical framework and validation (2014) (23)
Etiology of AIDS-related Kaposi's sarcoma and lymphoma. (1997) (23)
Getting to know HIV (2000) (23)
Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas (2015) (22)
HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study. (1999) (22)
Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes (2019) (21)
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank (2019) (21)
Genetic Transmission of RNA Tumor Viruses (1975) (21)
Immunohistochemistry versus immunofluorescence for non-Hodgkin's lymphomas. (1980) (20)
The aetiology of Kaposi's sarcoma. (1991) (20)
Dysfunction of the proximal tubule underlies maleic acid-induced type II renal tubular acidosis. (1982) (20)
On Viruses, Discovery, and Recognition (2008) (19)
Viruses, cancer and AIDS. (1999) (19)
3 Experimental Biology and Assay of Retroviruses (1982) (19)
Ultrastructure and immunoelectron microscopy of human T-cell leukaemia virus type I-producing lymphoid and non-lymphoid human tumour cells. (1987) (19)
Cell transformation induced by Rous sarcoma virus: analysis of density dependence. (1971) (18)
Growth regulation and tumour formation of normal and neoplastic rat cells (1973) (18)
Dynamics of modern epidemics. (2005) (18)
Disubstituted Ferrocenyl Iodo- and Chalcogenoalkynes as Chiral Halogen and Chalcogen Bond Donors (2020) (18)
Detection of HIV envelope specific antibodies by immunoelectron microscopy and correlation with antibody titer and virus neutralizing activity. (1987) (18)
Two types of HTLV-1 particles are released from MT-2 cells. (1999) (18)
Virus Load and Sequence Variation in Simian Retrovirus Type 2 Infection (2000) (17)
Chiral Chalcogen Bond Donors Based on the 4,4′-Bipyridine Scaffold (2019) (17)
Exchange of Genetic Sequences Between Viruses and Hosts. (2017) (17)
Addressing controversies over Kaposi's sarcoma. (2000) (17)
Enantioseparation of fluorinated 3-arylthio-4,4'-bipyridines: Insights into chalcogen and π-hole bonds in high-performance liquid chromatography. (2018) (17)
Retroviral zoonoses (1998) (16)
Retroviruses: ancient and modern. (1999) (16)
Chalcogen Bonding Catalysis with Telluronium Cations. (2021) (15)
Comparative enantioseparation of chiral 4,4'-bipyridine derivatives on coated and immobilized amylose-based chiral stationary phases. (2020) (15)
Modulation of rat bronchoalveolar lavage cell function by the intratracheal delivery of interferon-gamma. (1988) (15)
Retroviruses and human disease. (1987) (15)
Blocking the docking of HIV-1 (2003) (14)
Retrovirus Receptors and their Genetics (1981) (13)
A new human retrovirus: a role in lymphoma? (1998) (13)
Adventitious viral genomes in vaccines but not in vaccinees. (2001) (13)
CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro. (1992) (12)
Two Types of HTLV-1 Particles Are Released from MT-2 Cells (1999) (12)
Fulminant human T cell leukaemia lymphoma masquerading as acute viral infection of the nervous system. (1983) (12)
Mission now possible for AIDS fund (2001) (12)
Role of CD4 in the penetration of cells by HIV. (1991) (12)
Retrovirus infections among patients treated in Britain with various clotting factors. (1986) (12)
Absence of H1° from quiescent chicken cells (1981) (12)
Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4′-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors (2020) (11)
Is AIDS Man-Made? (1999) (11)
Chimeric Matrix Proteins Encoded by Defective Proviruses with Large Internal Deletions in Human T-Cell Leukemia Virus Type 1-Infected Humans (2000) (11)
Lessons from naked apes and their infections (2007) (10)
Studies on the biogenesis of an enzymatically active complex III of the respiratory chain from yeast mitochondria. (1980) (10)
A perspective on the early days of RAS research (2020) (10)
A truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions. (1994) (10)
Natural and iatrogenic factors in human immunodeficiency virus transmission. (2001) (10)
Infectious diseases: An ill wind for wild chimps? (2009) (10)
Establishing a KSHV1 Cell Line (BCP-1) From Peripheral Blood and Characterizing Its Growth in Nod/SCID Mice (1998) (10)
Crystal Structure and Size-Dependent Neutralization Properties of HK 20 , a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp 41 (2010) (10)
Infection hazards of xenotransplantation: Retrospect and prospect (2018) (9)
Factors Impacting σ- and π-Hole Regions as Revealed by the Electrostatic Potential and Its Source Function Reconstruction: The Case of 4,4′-Bipyridine Derivatives (2020) (9)
Robert Koch: The Grandfather of Cloning? (2005) (9)
Retroviruses and human cancer. (1992) (9)
AIDS: unbeatable 20 years on (2001) (9)
Ancient and modern retroviruses. (2000) (8)
Response: Association of Duffy Antigen Genotypes with HIV-AIDS Susceptibility (2009) (8)
Detection and quantitation of human immunodeficiency virus type-1 particles by confocal microscopy. (2004) (8)
Occurrence of human herpes virus 8 in Kaposi's sarcoma and other tumours in South Africa. (1997) (8)
Retroviruses and cancer (2000) (8)
Inoculation of New World Primates With the Human Immunodeficiency Virus (1989) (8)
Diagnostic tests and clinical subsets in systemic lupus erythematosus: update 1983. (1983) (8)
Cancer processes in immunodeficient populations: an introduction. (2001) (8)
Establishing a KSHV 1 Cell Line ( BCP-1 ) From Peripheral Blood and Characterizing Its Growth in Nod / SCID Mice (1998) (8)
Enantioseparation of 5,5′-Dibromo-2,2′-dichloro-3-selanyl-4,4′-bipyridines on Polysaccharide-Based Chiral Stationary Phases: Exploring Chalcogen Bonds in Liquid-Phase Chromatography (2021) (7)
The oncologist's debt to the chicken (1998) (7)
Enantioseparations of polyhalogenated 4,4’‐bipyridines on polysaccharide‐based chiral stationary phases and molecular dynamics simulations of selector–selectand interactions (2021) (7)
Kaposi sarcoma herpesvirus : new perspectives (2007) (7)
Localized pulmonary neutrophil influx induced by lung lavage in sheep (2007) (6)
Certain promise and uncertain peril (2000) (6)
HIV and AIDS in relation to other pandemics. Among the viruses plaguing humans, HIV is a recent acquisition. Its outstanding success as an infection poses immense scientific challenges to human health and raises the question "What comes nest?". (2003) (6)
Waiting for Vaccine (2001) (6)
MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. (2001) (6)
HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes (2010) (6)
Why cell biologists should be aware of genetically transmitted viruses. (1978) (5)
Human Immunodeficiency Virus Type 2 Infection and Fusion of CD 4-Negative Human Cell Lines : Induction and Enhancement by Soluble CD 4 (5)
Dynamic spatiotemporal brain analyses of the visual checkerboard task: Similarities and differences between passive and active viewing conditions. (2016) (5)
Success hinges on support for treatment (2001) (5)
The Clammy Grip of Parasitic Tumors (2015) (5)
A sexually transmitted parasitic cancer (2006) (5)
Seroconversion of human T cell lymphotrophic virus III (HTLV-III) in patients with haemophilia: a longitudinal study. (1985) (5)
Sequence Note: Mutations in the vpu, env, and nef Genes of a Syncytium-Inducing Variant of HIV Type 1 JR-CSF That Infects a Range of T Cell Lines (1996) (5)
Kaposis sarcoma-associated herpesvirus and Kaposis sarcoma in Africa. (1996) (5)
A Plea for Justice for Jailed Medical Workers (2006) (5)
CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL. (1964) (4)
Genetics and evolution of RNA tumor viruses (1974) (4)
Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes. (2010) (4)
Among the viruses plaguing humans, HIV is a recent acquisition. Its outstanding success as an infection poses immense scientific challenges to human health and raises the question "What comes next?" (2003) (4)
Degradation of p 27 Kip cdk inhibitor triggered by Kaposi ’ s sarcoma virus cyclin – cdk 6 complex (2013) (4)
Protecting fetal development (2019) (4)
Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica - Response (1998) (4)
Lack of reverse transcriptase activity in serum in sporadic post‐transfusional and presumed epidemic or water‐borne forms of severe non‐A, non‐B hepatitis (1988) (4)
Oncogenic g-herpesviruses: an expanding family (2001) (3)
Activation of rat pulmonary lavage cells by intratracheal administration of polyinosinic-polycytidilic acid. (1990) (3)
Mutations in the vpu, env, and nef genes of a syncytium-inducing variant of HIV type 1 JR-CSF that infects a range of T cell lines. (1996) (3)
SEROLOGIC EVIDENCE FOR DIFFERENT ROUTES OF TRANSMISSION OF HHV-8 IN DIFFERENT POPULATIONS (1998) (3)
What's the host and what's the microbe? The Marjory Stephenson Prize Lecture 2015. (2015) (3)
Viral mechanisms of carcinogenesis. (1982) (3)
Circe, Cassandra, and the trojan pigs: xenotransplantation. (2004) (3)
Insight into the Modes of Activation of Pyridinium and Bipyridinium Salts in Non-Covalent Organocatalysis (2021) (3)
Viruses: Impact on Science and Society (2020) (2)
Retroviruses and Xenotransplantation (2001) (2)
Cancer: A Comprehensive Treatise. Volume 2. Etiology: Viral Carcinogenesis (1976) (2)
New challenges to health: The emergence of human immunodeficiency viruses and AIDS (2001) (2)
Xenotransplantation: Pausing To Reflect (2000) (2)
A robust lentiviral pseudotype neutralisation assay for rabies and lyssavirus serology (2009) (2)
Mutant retrovirus particles package vesicular stomatitis virus mRNA during mixed infection. (1981) (2)
Interactions between cells with different degrees of malignancy. (1970) (2)
Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I. (1984) (2)
Remembering Jan Svoboda: A Personal Reflection (2018) (2)
Open questions: knowing who’s who in multicellular animals is not always as simple as we imagine (2018) (2)
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site. (2022) (2)
6 – Receptors for Human Retroviruses (1991) (2)
Human retroviruses in health and disease. (1984) (2)
DEFECTIVE HTLV-1 PROVIRUSES WITH LARGE INTERNAL DELETIONS ARE CODING FOR CHIMERIC PROTEINS (1999) (1)
Proceedings: Genetics and the cancer cell: cell genetics and growth of endogenous viruses. (1972) (1)
IDENTIFICATION OF HHV-8 SPECIFIC CYTOTOXIC T CELL RESPONSES (1999) (1)
Perspectives on endogenous retroviruses in normal and pathological growth. (1982) (1)
Cell transformation induced by Rous sarcoma virus: analysis of density dependence. (1971) (1)
Critical Review HIV Receptors and Cellular Tropism (2002) (1)
Comparison of bronchoalveolar lavage cells from germfree and conventional lambs. (1985) (1)
Growth Control Between Dissimilar Cells in Culture (2008) (1)
ANALYSIS OF THE HIV ENVELOPE BINDING DOMAIN ON CD4 THROUGH SITE-DIRECTED MUTAGENESIS (1990) (1)
Introduction to oncogenesis by RNA tumor viruses. (1979) (1)
The Biology of RNA Tumour Viruses (1979) (1)
Viral contaminants of xenografts (1980) (1)
Clinical conferences at The Johns Hopkins Hospital: Kaposi's sarcoma. (1982) (1)
Diagnostic utility of morphologic criteria encountered in malignant lymphoid cells. (1981) (1)
Chronic Infections of C-Type RNA Viruses (1977) (1)
Biological properties of HTL VIII (1985) (1)
Cofactors, coreceptors, and new retroviruses. An interview with Robin A Weiss, PhD. Interview by Mark Mascolini. (1995) (1)
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors [see comments] (1997) (1)
Influence of Duffy antigen receptor for chemokines on HIV infection (2013) (1)
2 Human Receptors for Retroviruses (1994) (1)
Reflections on the Virulence of Infections (2017) (1)
70th Anniversary Collection of the Microbiology Society: Journal of General Virology. (2015) (1)
Retrovirus Receptors and Cell Tropism (1989) (1)
ASSOCIATION BETWEEN HHV8, HIV, CANCER AND SELECTED RISK FACTORS IN SOUTH AFRICA (1998) (1)
Emerging infections: what have we learnt from SARS? Papers of a Discussion Meeting held at The Royal Society on 13 January 2004 - Introduction (2004) (1)
Chris Marshall (1949–2015) (2015) (1)
Introduction. Emerging infections: what have we learnt from SARS? (2004) (1)
A novel serological assay for detection of rabies virus neutralising antibodies (2007) (1)
Chance Favors the Prepared Mind (2002) (1)
Research investment: Vaccine research loses out (2011) (1)
Chalcogen‐Bonding Catalysis with Telluronium Cations (2021) (1)
For the T-cell surface protein coding t4 dna and use of t4-fragments in the treatment of AIDS (1987) (0)
Alan F. Williams: an Appreciation (1993) (0)
11 The Search for Human RNA Tumor Viruses (1982) (0)
BOX 1 NATURAL WEAPONS OF MASS DESTRUCTION PLACED ON A ‘ RICHTER ’ SCALE (2004) (0)
antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C. (2012) (0)
A novel serological assay for the detection of rabies virus and lyssavirus neutralising antibodies (2008) (0)
positive plasmablastic lymphoma - is linked to HHV-8 HHV-8 is associated with a plasmablastic variant of Castleman disease that (2013) (0)
Novel human and porcine retroviruses. (2000) (0)
Heterosexual transmission of HIV-1 infection in UK (2001) (0)
The implications for ‘in-field’ sero-surveillance and evaluation of vaccines targeting rabies using lacZ based lentiviral pseudotypes (2009) (0)
Commentary 70 th Anniversary Collection of the Microbiology Society : Journal of General Virology (2015) (0)
Deciphering the Role of Noncovalent Interactions in the Conformations of Dibenzo-1,5-dichalcogenocines. (2022) (0)
Crystal structure of anti-HIV llama VHH antibody A12 (2012) (0)
crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix (2010) (0)
Evolutionary genetics and the emergence of SARS coronavirus. (2005) (0)
HHV-8 infection in blood donors and patients with malignant and reactive lymphoproliferations from different regions of Italy (1998) (0)
Chris Marshall (1949-2015) Obituary (2015) (0)
Retroviral vectors are produced by resistant to lysis by human serum production cell (1995) (0)
Cancer, infection and immunity: a personal homage to Jan Svoboda. (2004) (0)
Effect of Duffy antigen receptor for chemokine (DARC) polymorphisms on susceptibility to HIV infection and progression to AIDS (2007) (0)
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1408) (2001) (0)
Celebrating novel cancer drugs (2003) (0)
Ameliorations relatives a l'isolation de virus et a l'utilisation des virus isoles (1986) (0)
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile (2003) (0)
HIV-1 infection of human neuronal cultures results in aberrant neurotransmitter synthesis (2008) (0)
Response: HIV Fusion (1996) (0)
Xenotransplantation (1998) (0)
Letter from Robin A. Weiss, Institute of Cancer Research to Harold Varmus (1982) (0)
HIV: Helping Save Lives Through Early Diagnosis (2012) (0)
Response from Weiss: Evolution of virulence: adaptive or not? (2003) (0)
BJC moves forward (2002) (0)
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 359 (1447) (2004) (0)
Oncogenic Viruses and Cancer Transmission (2012) (0)
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1410) (2001) (0)
Characterization of monoclonal antibodies raised against the latent nuclear antigen (LNA) of human herpesvirus-8 (1999) (0)
Absence of H1 degree from quiescent chicken cells. (1981) (0)
The evaluation of antibody responses to rabies virus using retroviral pseudotypes and the implications for ‘in-field’ vaccine trials (2008) (0)
Workings of HIV: HIV and the Pathogenesis of AIDS . Jay A. Levy. ASM Press, Washington, DC, 1994. xiv, 359 pp., illus., + plates. Paper, $49; to American Society for Microbiology members, $39. (1995) (0)
Quantitative Fit Factor Evaluation of Schistosome Topical Antipenetrant (TAP) (1993) (0)
Infectious Nobelitis (2006) (0)
HIV TARGET-CELL INTERACTIONS (1990) (0)
When will prevention of HTLV-III infection be possible? (1984) (0)
Chalcogen-Bond Catalysis: Telluronium-Catalyzed [4+2]-Cyclocondensation of (in situ Generated) Aryl Imines with Alkenes. (2022) (0)
DNA encoding the T cell surface protein T4 and use of T-4 in the treatment of AIDS (1988) (0)
Duffy Antigen Receptor for Chemokines: a Polymorphism Frequent in Africans that Increases Risk of HIV-1 Infection by 50% (2008) (0)
Antibody Research Method and equipment or kit for the implementation of such process (1986) (0)
Discovering How Our Senses Work at High-resolution Levels Mediating Our Sensory Experience through Machine Interfaces Remixing Our Senses for Different Experiences (0)
Towards an ultra-rapidsmartphone- connected test forinfectious diseases (2017) (0)
Does HIV cause AIDS? (1989) (0)
Test method for the detection of antibodies to retroviruses and undersoegelsessaet to consider approval hereby (1986) (0)
Virology: Potent tiny packages (2011) (0)
H-102 Speaking in honor of Peter Vogt: Pseudoviruses (2017) (0)
Transplants of the future (2001) (0)
Of viruses and men (2000) (0)
The efficacy of current vaccines and novel Nanobody-based antivirals against highly pathogenic rabies and lyssaviruses (2010) (0)
Cadmium chloride induces b7.1 expression in mur1ne renal tubular cells (1996) (0)
REVIEW ARTICLE Infection Hazards of Xenotransplantation (2000) (0)
Neutralisation of HIV-1 cell-cell spread by human and llama antibodies (2014) (0)
Crystal structure of anti-HIV llama VHH antibody A12 in complex with C186 gp120 (2012) (0)
CHARACTERIZATION OF A HUMAN SERUM SELECTED HIV-1 ESCAPE MUTANT RESISTANT TO NEUTRALIZATION BY MONOCLONAL-ANTIBODIES MAPPING TO THE CD4 BINDING-SITE OF GP120 (1993) (0)
Recent experience with xenotransplantation reminds us that the risk of infection by animal microbes has not been uppermost in the mind of every transplant surgeon (2013) (0)
Editorial (2004) (0)
DNA encoding the T cell surface protein T4, and using T4 fragments in the treatment of AIDS (1988) (0)
Infectious disease: Chronicles of a killer virus (2012) (0)
Several variants of HHV-8 are present in biopsies of HIV-negative “classical” and transplant-associated Kaposi's sarcoma (2007) (0)
Getting to know HIV : Current status of knowledge on the epidemiology, natural history and control of HIV/AIDS (2000) (0)
Murchison of an Ancient Cell Lineage Transmissable Dog Cancer Genome Reveals the Origin and History (2014) (0)
AIDS and cancer (2001) (0)
Localization oftheReceptor GeneforTypeD Simian Retroviruses on HumanChromosome 19 (1990) (0)
Development of a novel serological assay for the detection of rabies virus neutralising antibodies using lentiviral pseudotypes (2010) (0)
If free speech costs lives that's a high price to pay (2000) (0)
T4: A T-Cell Surface Protein Mediating Cell-Cell and Cell-AIDS Virus Interactions (1987) (0)
Large animal model for health hazard assessment of environmental pollutants (1984) (0)
8-Specific Cytotoxic T-Cell Responses Identification of Human Herpesvirus (2013) (0)
Common and Variable Neutralization Epitopes of HIV-1 and HIV-2 (1988) (0)
The efficacy of current rabies vaccines and novel Nanobody®-based antivirals against highly pathogenic phylogroup -1 and -2 members of the Lyssavirus genus (2010) (0)
Cellular Pathogenesis of Human Immunodeficiency Viruses Types 1 and 2 (1992) (0)
ORIGIN OF THE ENDOGENOUS AVIAN RETROVIRUS, RAV-O (1980) (0)
The Role of CD4 Antigen in HIV Infection (1989) (0)
The oncologists' and radiologists' PET (2003) (0)
Retroviruses and human disease HTLV-1 and adult T cell leukaemia Adult (2005) (0)
Characterisation of persistent viral infections in bats (2007) (0)
Comprar Kaposi Sarcoma Herpesvirus: New Perspectives | Boshoff, C. | 9783540343431 | Springer (2007) (0)
S195 The role of HHV-8 for the pathogenesis of Kaposi's sarcoma (1997) (0)
[Specific antibodies against human T cell leukemia virus found in AIDS patients]. (1984) (0)
Chalcogen Bonding with Diaryl Ditellurides: Evidence from Solid State and Solution Studies. (2022) (0)
What Role Do Macrophages and Dendritic Cells Play in AIDS ? (2005) (0)
Deciphering the Role of Noncovalent Interactions in the Conformations of Dibenzo‐1,5‐dichalcogenocines (2022) (0)
SOLUBLE CD4 BINDING TO HIV-1 VIRIONS CAUSES GP120 TO DISSOCIATE FROM GP41 (1991) (0)
HumanImmunodeficiency VirusType2Infection andFusionof CD4-Negative HumanCellLines: Induction and Enhancement bySoluble CD4 (1992) (0)
COURSE: Novel vaccination strategies against the three major killers (2014) (0)
HHV-8 SEROPREVALENCE AND DNA SEQUENCES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES AND NORMAL POPULATION FROM ITALY: 106 (1997) (0)
Retroviruses as host Mendelian elements. (1983) (0)
Effect of NH 4 CI on VSV pseudotype infection (2007) (0)
Oncogenes, their role in normal and malignant growth : proceedings of a Royal Society Discussion Meeting held on 5 and 6 December 1984 (1985) (0)
Memorial to Bill Hamilton (2001) (0)
Chalcogen Bonding with Diaryl Ditellurides: Evidence from Solid‐State and Solution Studies (2022) (0)
How RNA Makes DNA: Reverse Transcriptase . Anna Marie Skalka and Stephen P. Goff, Eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1993. xii, 492 pp., illus. $85. Cold Spring Harbor Monograph 23. (1994) (0)
THE DISTRIBUTION OF HHV-8 LATENTLY INFECTED CELLS IN ALL STAGES OF KAPOSI'S SARCOMA (1999) (0)
Open questions: knowing who’s who in multicellular animals is not always as simple as we imagine (2018) (0)
Biological properties of HTLVIII. (1985) (0)
Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gpl20 (acquired (0)
Retroviral Receptors and Interference on Human Cells (1989) (0)
Thirty years on: HIV receptor gymnastics and the prevention of infection (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robin A Weiss?

Robin A Weiss is affiliated with the following schools:

Robin A Weiss's Academic­Influence.com Rankings

Why Is Robin A Weiss Influential?

Robin A Weiss's Published Works

Published Works

What Schools Are Affiliated With Robin A Weiss?

Robin A Weiss's AcademicInfluence.com Rankings